| | Diabetesa | Cholesterolb | Hypertensionc |
|---|
OR (95%-CI) | OR (95%-CI) | OR (95%-CI) |
|---|
IBd |
- High | 2.54 (0.67–9.67) | 1.27 (0.70–2.31) | 1.47 (0.82–2.65) |
- Intermediate | 0.99 (0.27–3.66) | 1.26 (0.73–2.17) | 1.45 (0.85–2.47) |
- Low | Reference | Reference | Reference |
- With the term infection we in this study refer to antibody seropositivity, a measure reflecting current or past infection; a:Diabetes was determined by glucose > 11.0 mmol/L and/or HbA1c > 6.5%, after exclusion of people with self-reported diabetes; b: Elevated cholesterol was measured by total/HDL-cholesterol ≥5 mmol/L, after exclusion of people with self-reported dyslipidemia; d, c: Hypertension was measured by DBP ≥ 90 mmHg or SBP ≥ 140 mmHg, after exclusion of people with self-reported hypertension; d: IB = infectious burden measured by the number of infections (HSV1, HSV2, HAV, HBV, HCV and H.pylori) a participant was seropositive for. With the term infection we in this study refer to antibody seropositivity, a measure reflecting current or past infection. The subcategories are: low (0–2 infections), intermediate (3 infections) and high (4–6 infections)
